What is Deep Pharma Intelligence?
Deep Pharma Intelligence, a UK-based entity and subsidiary of Deep Knowledge Group, operates at the intersection of pharmaceutical, biotech, and healthcare industries. The company specializes in providing advanced market intelligence, focusing on biotech innovation profiling and development advisory. Leveraging artificial intelligence and big data analytics, Deep Pharma Intelligence offers data mining, visualization systems, and interactive analytics tools to deliver deep technical insights and strategic guidance in high-growth sectors. Their client base includes entities within the biotech and healthcare ecosystems seeking to navigate complex market dynamics and capitalize on emerging opportunities.
How much funding has Deep Pharma Intelligence raised?
Deep Pharma Intelligence has raised a total of $50M across 1 funding round:
Series D
$50M
Series D (2026): $50M with participation from XIN DING Capital, CDH Investments, and HSG
Key Investors in Deep Pharma Intelligence
XIN DING Capital
XIN DING Capital is an AI professional service organization focused on market value management and comprehensive solutions for Chinese listed companies, offering consulting and digital solutions to enhance corporate governance and operational efficiency.
CDH Investments
CDH Investments, established in 2002 and headquartered in Hong Kong, is an investment firm with a broad portfolio spanning private equity, real estate, public equity, and wealth management.
HSG
HSG is a prominent exterior building service company in Southern California with over 40 years of experience in waterproofing, restoration, and window cleaning, dedicated to property maintenance and enhancement.
What's next for Deep Pharma Intelligence?
The recent major strategic investment signifies a pivotal moment for Deep Pharma Intelligence, likely enabling accelerated expansion of its data analytics platforms and intelligence services. This capital infusion is expected to bolster its capabilities in AI-driven market analysis and further solidify its role as a key advisor in the rapidly evolving pharmaceutical and biotech landscapes. The company is poised to enhance its offerings, potentially exploring new verticals or deepening its existing market penetration to support innovation and strategic decision-making for its clientele.
See full Deep Pharma Intelligence company page
